Asset Management One
EGRX

Asset Management One’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Asset Management One’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-89,729
Closed -$6.28M – 1235
2016
Q3 		$6.28M Sell
89,729
-9,935
-10% -$550K 0.09% 243
2016
Q2 		$3.88M Sell
99,664
-5,247
-5% -$218K 0.06% 377
2016
Q1 		$4.1M Buy
104,911
+6,409
+7% +$407K 0.06% 369
2015
Q4 		$8.96M Buy
98,502
+5,361
+6% +$423K 0.13% 179
2015
Q3 		$6.88M Sell
93,141
-23,617
-20% -$1.96M 0.1% 245
2015
Q2 		$8.8M Sell
116,758
-38,702
-25% -$2.52M 0.12% 213
2015
Q1 		$6.3M Buy
+155,460
New +$4.41M 0.08% 322

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Asset Management One's EGRX Position: Q4 2016 in Review

Asset Management One sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2016, closing a stake of 89,729 shares — an estimated $6.28M sold.

Asset Management One first reported a position in EGRX in Q1 2015 and held it in 7 quarters. The position peaked at $8.96M in Q4 2015. 149 funds tracked by Wall St. Rank hold EGRX as of Q4 2016.

  • Asset Management One reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 89,729 Eagle Pharmaceuticals, Inc. shares in Q4 2016, an estimated $6.28M.
  • Asset Management One first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2015 and held it in 7 quarters.
  • Asset Management One's Eagle Pharmaceuticals, Inc. position peaked at $8.96M in Q4 2015.
  • 149 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.